Filing Flows › Solesence (SLSN) › Q2 2025
Solesence (SLSN) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 14, 2025
Solesence (SLSN) reported revenue of $20.4M for the second quarter 2025 (Q2 2025), +56% from a year earlier and +39% from the quarter before. Operating margin was 9.4%, net earnings $2.7M (13.1% of revenue).
Solesence, Q2 2025: revenue $20.4M (+56% year over year), operating margin 9.4%, net earnings $2.7M, operating cash flow −$654K. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.4M | +39% | +56% |
| Gross profit | $5.9M | +74% | +57% |
| Operating profit | $1.9M | +646% | +82% |
| Net earnings | $2.7M | 33× | +212% |
| Operating cash flow | −$654K | — | — |
What changed
Revenue was $20.4M in Q2 2025, up 56% year over year and up 39% from the previous quarter. Consumer Products was the largest line at 86% of revenue. Consumer Products added $6.3M year over year (up 57%), 87% of the total change.
Gross margin was 28.9%, up 0.2 points from a year earlier. Operating profit was $1.9M, a 9.4% margin (up 1.4 points year over year). Of the extra revenue versus a year earlier, 12% reached operating profit, above the 8% margin then. Operating expenses grew 47% against revenue growth of 56%. The fastest-growing cost line was SG&A (+65%). Net earnings were $2.7M, up 212% year over year. The effective tax rate was 12.8%. Non-operating items added $1.1M, 38% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$654K. Non-cash charges added back $225K of depreciation and amortization and $120K of share-based compensation. Working capital and other items used $3.7M.
Questions
What was Solesence's revenue in the second quarter 2025?
Solesence (SLSN) reported revenue of $20.4M for the second quarter 2025 (Q2 2025), +56% from a year earlier and +39% from the quarter before.
Was Solesence profitable in the second quarter 2025?
Operating profit was $1.9M (9.4% of revenue) and net earnings $2.7M.
Source: Solesence 10-Q on SEC EDGAR.